Journal of Neuroscience, Vol 8, 2414-2421, Copyright © 1988 by Society for Neuroscience
Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy
AS Basile, SH Gammal, KD Mullen, EA Jones and P Skolnick
Laboratory of Neuroscience, NIDDK, Bethesda, Maryland 20892.
The role of the GABA-benzodiazepine receptor complex in the pathogenesis of
hepatic encephalopathy was investigated by recording the
electrophysiological responses of single cerebellar Purkinje neurons from
rabbits with hepatic encephalopathy due to galactosamine- induced fulminant
hepatic failure. Both the GABAmimetic muscimol and the benzodiazepine
receptor agonist flunitrazepam were 3-4 times more potent in depressing the
spontaneous activity of Purkinje neurons from rabbits with hepatic
encephalopathy than from control animals. Furthermore, qualitatively
different responses of Purkinje neurons to benzodiazepine receptor
antagonists (Ro 15-1788 and Ro 14-7437) were found in controls and rabbits
with hepatic encephalopathy. These compounds markedly excited Purkinje
neurons from rabbits with hepatic encephalopathy, but had either no effect
(Ro 14-7437) or partially suppressed (Ro 15-1788) the spontaneous activity
of neurons from control animals. In addition, incubation of Purkinje
neurons from rabbits with hepatic encephalopathy with subthreshold
concentrations of Ro 14-7437 reduced their sensitivity to muscimol, whereas
treatment of control neurons with Ro 14-7437 had no effect on their
sensitivity to muscimol. Finally, Purkinje neurons from hepatic
encephalopathy and control rabbits displayed no difference in sensitivity
to the depressant actions of the alpha-adrenoceptor agonist phenylephrine.
These findings demonstrate a differential responsiveness of Purkinje
neurons from an animal model of hepatic encephalopathy to ligands that
interact with the GABA-benzodiazepine receptor complex. Furthermore, the
observations made in this experimental model are consistent with the
involvement of the GABA-benzodiazepine receptor complex in mediating
hepatic encephalopathy, and provide a potential explanation for the
reported efficacy of benzodiazepine receptor antagonists in ameliorating
this syndrome.